166 related articles for article (PubMed ID: 20061936)
21. Atypical prostatic glandular proliferations on needle biopsy: Diagnostic implications, use of immunohistochemistry, and clinical significance.
Samaratunga H; Gardiner RA; Yaxley J; Brown I
Anal Quant Cytol Histol; 2006 Apr; 28(2):104-10. PubMed ID: 16637513
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of whole slide image immunohistochemistry interpretation in challenging prostate needle biopsies.
Fine JL; Grzybicki DM; Silowash R; Ho J; Gilbertson JR; Anthony L; Wilson R; Parwani AV; Bastacky SI; Epstein JI; Jukic DM
Hum Pathol; 2008 Apr; 39(4):564-72. PubMed ID: 18234276
[TBL] [Abstract][Full Text] [Related]
23. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
Shah RB; Magi-Galluzzi C; Han B; Zhou M
Am J Surg Pathol; 2010 Apr; 34(4):470-7. PubMed ID: 20182345
[TBL] [Abstract][Full Text] [Related]
24. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens.
Evans AJ; Henry PC; Van der Kwast TH; Tkachuk DC; Watson K; Lockwood GA; Fleshner NE; Cheung C; Belanger EC; Amin MB; Boccon-Gibod L; Bostwick DG; Egevad L; Epstein JI; Grignon DJ; Jones EC; Montironi R; Moussa M; Sweet JM; Trpkov K; Wheeler TM; Srigley JR
Am J Surg Pathol; 2008 Oct; 32(10):1503-12. PubMed ID: 18708939
[TBL] [Abstract][Full Text] [Related]
25. Lesions missed on prostate biopsies in cases sent in for consultation.
Kronz JD; Milord R; Wilentz R; Weir EG; Schreiner SR; Epstein JI
Prostate; 2003 Mar; 54(4):310-4. PubMed ID: 12539230
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
Shah RB; Kunju LP; Shen R; LeBlanc M; Zhou M; Rubin MA
Am J Clin Pathol; 2004 Oct; 122(4):517-23. PubMed ID: 15487448
[TBL] [Abstract][Full Text] [Related]
27. [Histological findings in 100 needle prostatic biopsies and original diagnosis of benignity].
Arista-Nasr J; Gómez-Bustamante D; Aguilar-Magaña FA; Saqui-Salces M; Martínez-Benítez B
Rev Invest Clin; 2006; 58(2):88-93. PubMed ID: 16827260
[TBL] [Abstract][Full Text] [Related]
28. [Low-stage prostatic adenocarcinoma and atypical lesions of the prostate].
Maganto Pavón E; García González R; Ruiz Zárate C; Fernández González I; Fernández Fernández A; Vallejo Herrador J; Mateos Torres A; Escudero Barrilero A
Arch Esp Urol; 1990; 43(9):967-70. PubMed ID: 1708979
[TBL] [Abstract][Full Text] [Related]
29. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.
Borboroglu PG; Sur RL; Roberts JL; Amling CL
J Urol; 2001 Sep; 166(3):866-70. PubMed ID: 11490235
[TBL] [Abstract][Full Text] [Related]
30. Prostate adenocarcinoma detected after high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation.
López JI
BJU Int; 2007 Dec; 100(6):1272-6. PubMed ID: 17850386
[TBL] [Abstract][Full Text] [Related]
31. Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.
Lane Z; Epstein JI; Ayub S; Netto GJ
Hum Pathol; 2008 Apr; 39(4):543-9. PubMed ID: 18234278
[TBL] [Abstract][Full Text] [Related]
32. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
33. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry in the workup of prostate biopsies: Frequency, variation and appropriateness of use among pathologists practicing at an academic center.
Al Diffalha S; Shaar M; Barkan GA; Wojcik EM; Picken MM; Pambuccian SE
Ann Diagn Pathol; 2017 Apr; 27():34-42. PubMed ID: 28325359
[TBL] [Abstract][Full Text] [Related]
35. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
Harden SV; Guo Z; Epstein JI; Sidransky D
J Urol; 2003 Mar; 169(3):1138-42. PubMed ID: 12576869
[TBL] [Abstract][Full Text] [Related]
36. Atypical small acinar proliferation: biopsy artefact or distinct pathological entity?
Flury SC; Galgano MT; Mills SE; Smolkin ME; Theodorescu D
BJU Int; 2007 Apr; 99(4):780-5. PubMed ID: 17378841
[TBL] [Abstract][Full Text] [Related]
37. Xanthoma of the prostate: a mimicker of high-grade prostate adenocarcinoma.
Chuang AY; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1225-30. PubMed ID: 17667547
[TBL] [Abstract][Full Text] [Related]
38. Reassessing the diagnostic yield of saturation biopsy of the prostate.
Ashley RA; Inman BA; Routh JC; Mynderse LA; Gettman MT; Blute ML
Eur Urol; 2008 May; 53(5):976-81. PubMed ID: 17997028
[TBL] [Abstract][Full Text] [Related]
39. Electronic expert consultation using digital still images for evaluation of atypical small acinar proliferations of the prostate: a comparison with immunohistochemistry.
Banihashemi A; Asgari M; Shooshtarizade T; Abolhasani M; Mireskandari M
Ann Diagn Pathol; 2014 Jun; 18(3):163-70. PubMed ID: 24767894
[TBL] [Abstract][Full Text] [Related]
40. Improvement of diagnostic agreement among pathologists in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies using a novel "Disease-Focused Diagnostic Review" quality improvement process.
Shah RB; Leandro G; Romerocaces G; Bentley J; Yoon J; Mendrinos S; Tadros Y; Tian W; Lash R
Hum Pathol; 2016 Oct; 56():155-62. PubMed ID: 27346573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
